PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Solving complex physics problems at lightning speed

Solving complex physics problems at lightning speed
2021-02-01
(Press-News.org) A calculation so complex that it takes twenty years to complete on a powerful desktop computer can now be done in one hour on a regular laptop. Physicist Andreas Ekström at Chalmers University of Technology, together with international research colleagues, has designed a new method to calculate the properties of atomic nuclei incredibly quickly.

The new approach is based on a concept called emulation, where an approximate calculation replaces a complete and more complex calculation. Although the researchers are taking a shortcut, the solution ends up almost exactly the same. It is reminiscent of algorithms from machine learning, but ultimately the researchers have designed a completely new method. It opens up even more possibilities in fundamental research in areas such as nuclear physics.

"Now that we can emulate atomic nuclei using this method, we have a completely new tool to construct and analyse theoretical descriptions of the forces between protons and neutrons inside the atomic nucleus," says research leader Andreas Ekström, Associate Professor at the Department of Physics at Chalmers.

Fundamental to understanding our existence The subject may sound niche, but it is in fact fundamental to understanding our existence and the stability and origin of visible matter. Most of the atomic mass resides in the centre of the atom, in a dense region called the atomic nucleus. The constituent particles of the nucleus, the protons and neutrons, are held together by something called the strong force. Although this force is so central to our existence, no one knows exactly how it works. To increase our knowledge and unravel the fundamental properties of visible matter, researchers need to be able to model the properties of atomic nuclei with great accuracy.

The basic research that Andreas Ekström and his colleagues are working on sheds new light on topics ranging from neutron stars and their properties, to the innermost structure and decay of nuclei. Basic research in nuclear physics also provides essential input to astrophysics, atomic physics, and particle physics.

Opening doors to completely new possibilities "I am incredibly excited to be able to make calculations with such accuracy and efficiency. Compared with our previous methods, it feels like we are now computing at lightning speed. In our ongoing work here at Chalmers, we hope to improve the emulation method further, and perform advanced statistical analyses of our quantum mechanical models. With this emulation method it appears that we can achieve results that were previously considered impossible. This certainly opens doors to completely new possibilities," says Andreas Ekström.

The project is funded by the European Research Council within the framework of an ERC Starting Grant.

Read more about the work to explore the secrets of the atomic nuclei.

More on the mathematical shortcut The new emulation method is based on something called eigenvector continuation (EVC). It allows for emulation of many quantum mechanical properties of atomic nuclei with incredible speed and accuracy. Instead of directly solving the time-consuming and complex many-body problem over and over again, researchers have created a mathematical shortcut, using a transformation into a special subspace. This makes it possible to utilise a few exact solutions in order to then obtain approximate solutions much faster.

If the emulator works well, it generates solutions that are almost exactly - circa 99 per cent - similar to the solutions to the original problem. This is in many ways the same principles used in machine learning, but it is not a neural network or a Gaussian process - a completely new method underpins it. The EVC method for emulation is not limited to atomic nuclei, and the researchers are currently looking further into different types of applications.

INFORMATION:

The new findings have been published in two articles:

"Eigenvector continuation as an efficient and accurate emulator for uncertainty quantification", published in Physics Letters B, written by Sebastian König, Andreas Ekström, Kai Hebeler, Dean Lee and Achim Schwenk. The researchers are active at North Carolina State University, USA, Chalmers University of Technology, Darmstadt University of Technology, Germany and Michigan State University, USA.

"Global Sensitivity Analysis of Bulk Properties of an Atomic Nucleus", published in Physical Review Letters, written by Andreas Ekström, Chalmers, and Gaute Hagen, Oak Ridge National Laboratory, USA.

For more information, please contact: Andreas Ekström, Associate Professor, Department of Physics, Chalmers University of Technology, Sweden, +46 31 772 36 85 andreas.ekstrom@chalmers.se


[Attachments] See images for this press release:
Solving complex physics problems at lightning speed

ELSE PRESS RELEASES FROM THIS DATE:

Just add mushrooms: Making meals more nutritious

Just add mushrooms: Making meals more nutritious
2021-02-01
February 1, 2021 - Researchers have identified another good reason to eat more mushrooms. New research , published in Food Science & Nutrition (January 2021) found that adding a mushroom serving to the diet increased the intake of several micronutrients, including shortfall nutrients such as vitamin D, without any increase in calories, sodium or fat. Dr. Victor L. Fulgoni III and Dr. Sanjiv Agarwal modeled the addition of mushrooms to National Health and Nutrition Examination Survey (NHANES) 2011-2016 dietary data looking at a composite of white, crimini and portabella mushrooms at a 1:1:1 ratio; one scenario including UV-light exposed mushrooms; and one scenario including oyster mushrooms ...

Larger panel finds more gene mutations, treatment targets for leukemia

Larger panel finds more gene mutations, treatment targets for leukemia
2021-02-01
AUGUSTA, Ga. (Feb. 1, 2020) - A gene panel that looks for about 10 times the number of cancer-causing genes as panels currently used to diagnose and fine tune treatment for a variety of cancers is effective at identifying problematic genes in the most common leukemia, investigators report. The 523-gene panel, developed by San Diego-based biotech company Illumina, which includes all genes known to potentially cause cancer, can be readily adopted for use in clinical laboratories to diagnose acute myeloid leukemia, or AML, the investigators report in the journal PLOS ONE. Identifying ...

Patient-reported outcomes from the randomized phase III CROWN study of first-line Lorlatinib versus in ALK+ NSCLC

2021-01-31
(Singapore--January 31, 2021 2:40 p.m. SPT 1:40 a.m. EST)--Patient-reported outcomes from the phase III CROWN study showed that time to treatment deterioration (TTD) in pain in chest, dyspnea, and cough was comparable between those who received lorlatinib and patients who took crizotinib. The research was presented today at the International Association for the Study of Lung Cancer's 2020 World Conference on Lung Cancer Singapore. Lorlatinib, a third-generation ALK inhibitor, significantly improved progression-free survival compared to crizotinib in ...

Social & structural factors influence racial disparities in COVID-19 mortality

2021-01-31
COVID-19 mortality racial disparities in the U.S. are associated with social factors like income, education and internet access, according to a Rutgers study. The study, published in the Journal of Racial and Ethnic Health Disparities, highlights the need for public health policies that address structural racism. The researchers investigated the association between COVID-19 cases and deaths in 2,026 U.S. counties from January to October 2020 and social determinants of health, which can raise the risk for infection and death. They also looked at factors known or thought to impact COVID-19 outcomes, including the counties' population density, days since the first COVID-19 death and percent of residents who are over age 65, are smokers or who have chronic diseases such as obesity, ...

ERAS program expedites recovery for congenital heart surgery patients

2021-01-30
CHICAGO (January 30, 2021) -- Select patients born with heart defects and who undergo congenital heart surgery recover with few complications and reduced opioid use when a comprehensive, evidence-based enhanced recovery after surgery (ERAS) program is used, according to research presented at the 57th Annual Meeting of The Society of Thoracic Surgeons. "We have embarked on a new paradigm for patient care with the goal of improving recovery, patient experience, and the value of care that we provide," said Nathalie Roy, MD, from Boston Children's Hospital in Massachusetts. ...

Women undergo less aggressive open heart surgery, experience worse outcomes than men

2021-01-30
CHICAGO (January 30, 2021) -- Women are significantly less likely than men to undergo coronary artery bypass grafting (CABG) using guideline-recommended approaches, which may result in worse outcomes after surgery, according to a scientific presentation at the 57th Annual Meeting of The Society of Thoracic Surgeons. "This study highlights key differences between women and men in surgical techniques used for CABG and reveals opportunities to improve outcomes in women," said Oliver K. Jawitz, MD, from Duke University in Durham, North Carolina. Using the STS Adult Cardiac Surgery Database--which contains records of nearly all CABG procedures performed in the US--Dr. Jawitz and colleagues from Duke and The Johns Hopkins University ...

'COVID effect' leads to fewer heart surgeries, more patient deaths

2021-01-30
CHICAGO (January 30, 2021) -- The most deadly global health crisis in a century has resulted in a substantial decline in overall heart surgery volume and an unexplained increase in deaths after coronary artery bypass grafting, according to late-breaking research presented at the 57th Annual Meeting of The Society of Thoracic Surgeons. "This study was a true herculean analysis and tour de force that showed the COVID effect on adult cardiac surgery volume, trends, and outcomes," said Tom C. Nguyen, MD, from the University of California San Francisco. "The pandemic has changed the world as we know it, causing a dramatic drop in adult cardiac surgery volume and worsening patient outcomes." Dr. Nguyen and colleagues queried the STS Adult ...

Nivolumab effective treatment for malignant mesothelioma

2021-01-30
(Singapore--January 30, 2021 11:00 p.m. SPT/January 30, 2021 10:00 a.m. EST)-- Nivolumab monotherapy is an effective treatment option for relapsed malignant mesothelioma (MM), according to research presented today at the International Association for the Study of Lung Cancer World Conference on Lung Cancer. Malignant mesothelioma is an intractable cancer, and no phase III trial has yet shown an improvement in overall survival following the standard first line chemotherapy doublet comprising pemetrexed and cisplatin or carboplatin since it was licensed in 2004. Professor Dean Fennell, chair of Thoracic Medical Oncology at the University of Leicester in collaboration with Professor Gareth Griffiths and his team at the Southampton Clinical Trials Unit, University of Southampton, ...

Selected gene mRNA expression is not predictive of improved overall survival

2021-01-30
(Singapore--January 30, 2021 11:00 p.m. SPT/January 30, 2021 10:00 a.m. EST)-- A phase III study examining whether messenger (m)RNA expression correlated with sensitivity or resistance to chemotherapy did not confer a statistically significant advantage in overall survival for patients with resected stage II-III non-small cell lung cancer (NSCLC), according to research presented at the International Association for the Study of Lung Cancer World Conference on Lung Cancer. Lung cancer researchers and clinicians have sought methods to improve chemotherapy's modest 5% overall survival rate for patients with NSCLC. Dr. Silvia Novello, professor of medical oncology at the University of Torino at ...

LCMC3: Neoadjuvant atezolizumab safe, meets primary endpoint of pathologic response rate

2021-01-30
(Singapore--January 30, 2021 11:00 p.m. SPT/January 30, 2021 10:00 a.m. EST)-- Primary analysis of the Lung Cancer Mutation Consortium (LCMC) 3 study revealed that neoadjuvant atezolizumab prior to lung cancer surgery was well tolerated by patients and met its primary endpoint of 20% major pathologic response rate, according to research presented today at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer. Dr. Jay M. Lee, chief, Division of Thoracic Surgery at Ronald Reagan UCLA Medical Center in Los Angeles, today reported on results from a study of 181 patients with stage IB to IIIB non-small cell lung ...

LAST 30 PRESS RELEASES:

HKU ecologists uncover significant ecological impact of hybrid grouper release through religious practices

New register opens to crown Champion Trees across the U.S.

A unified approach to health data exchange

New superconductor with hallmark of unconventional superconductivity discovered

Global HIV study finds that cardiovascular risk models underestimate for key populations

New study offers insights into how populations conform or go against the crowd

Development of a high-performance AI device utilizing ion-controlled spin wave interference in magnetic materials

WashU researchers map individual brain dynamics

Technology for oxidizing atmospheric methane won’t help the climate

US Department of Energy announces Early Career Research Program for FY 2025

PECASE winners: 3 UVA engineering professors receive presidential early career awards

‘Turn on the lights’: DAVD display helps navy divers navigate undersea conditions

MSU researcher’s breakthrough model sheds light on solar storms and space weather

Nebraska psychology professor recognized with Presidential Early Career Award

New data shows how ‘rage giving’ boosted immigrant-serving nonprofits during the first Trump Administration

Unique characteristics of a rare liver cancer identified as clinical trial of new treatment begins

From lab to field: CABBI pipeline delivers oil-rich sorghum

Stem cell therapy jumpstarts brain recovery after stroke

Polymer editing can upcycle waste into higher-performance plastics

Research on past hurricanes aims to reduce future risk

UT Health San Antonio, UTSA researchers receive prestigious 2025 Hill Prizes for medicine and technology

Panorama of our nearest galactic neighbor unveils hundreds of millions of stars

A chain reaction: HIV vaccines can lead to antibodies against antibodies

Bacteria in polymers form cables that grow into living gels

Rotavirus protein NSP4 manipulates gastrointestinal disease severity

‘Ding-dong:’ A study finds specific neurons with an immune doorbell

A major advance in biology combines DNA and RNA and could revolutionize cancer treatments

Neutrophil elastase as a predictor of delivery in pregnant women with preterm labor

NIH to lead implementation of National Plan to End Parkinson’s Act

Growth of private equity and hospital consolidation in primary care and price implications

[Press-News.org] Solving complex physics problems at lightning speed